My tabulation of the TOC comments on Relenza/Zanamivir had occupied my week preceding the meeting. What I found was interesting, surprising, and in some cases shocking. I decided to focus everyone's attention at the Oxford meeting by presenting some of the relevant extracts from the Medical Officer Review and the Statistical Officer Reviews as part of t…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.